HEALTH RELATED QUALITY OF LIFE AND HEALTH CARE RESOURCE USE BURDEN IN MIGRAINE WITH AND WITHOUT NAUSEA
Author(s)
Flores NM1, Lee LK1, Gajria K2, Pomerantz D3, Gandhi SK2
1Kantar Health, Foster City, CA, USA, 2Teva Pharmaceuticals Inc, Malvern, PA, USA, 3Kantar Health, Horsham, PA, USA
OBJECTIVES: To estimate the burden of nausea and/or vomiting (N/V) on sleep, depressive symptoms and health care resource use (HRU) in migraine patients. METHODS: Study data came from cross sectional, internet-based 2013 US National Health and Wellness Survey (NHWS). Survey participants self-reported their migraine frequency with or without N/V along with demographics, HRU in the previous 6 months (physician, emergency and hospital visits), sleep problems, and depressive symptoms. Sleep and depression outcomes were compared between migraineurs with or without N/V using Chi-square test. Adjusting for demographic and comorbidity differences, generalized linear models were conducted to compare HRU. RESULTS: Of the N=7855 migraine participants, 58% reported N/V symptoms, female= 73%, white= 72%, mean age= 41.8 (SD=14.0), mean Charlson-comorbidity index=0.55 (SD= 1.26) and mean migraine episodes (past 30 days)= 3.27(SD=5.33). Compared with migraineurs without N/V, significantly greater proportion of migraneurs with N/V reported depressive symptoms (39.2% vs 45.2%, p<0.001 ), sleep problems (e.g. sleep difficulty, 43.6% vs 54.1%; daytime sleepiness, 30.9% vs 40.4%; poor sleep quality, 28.9% vs 38.9%; nighttime awakening, 33.9% vs 44.2%, all p<0.001). Mean emergency room (ER) visits increased significantly by about 20% in migraneurs with N/V than without N/V [0.48 (95% CI = 0.41, 0.57) vs 0.38, [95% CI= 0.32, 0.45]; p<0.01). Between migraineurs with and without N/V, no significant increase in the mean number of physician [5.24 (95% CI = 4.82, 5.69) vs 4.93 (95% CI= 4.54, 5.35); p=0.06] and hospital visits [0.20 (95% CI = 0.16, 0.25) vs 0.19 (95% CI= 0.15, 0.24), p=0.65] were detected. CONCLUSIONS: Migraineurs with N/V reported worsened sleep and depressive symptom outcomes, and higher ER visits than those without N/V. Future research must evaluate the relationship of N/V severity on these outcomes. Study findings highlight opportunities for treatment options that may alleviate these unmet medical needs in migraineurs with N/V.
Conference/Value in Health Info
2015-05, ISPOR 2015, Philadelphia, PA, USA
Value in Health, Vol. 18, No. 3 (May 2015)
Code
PHS85
Topic
Patient-Centered Research
Topic Subcategory
Patient-reported Outcomes & Quality of Life Outcomes
Disease
Neurological Disorders